首页 | 本学科首页   官方微博 | 高级检索  
检索        

奈达铂联合5-Fu与顺铂联合5-Fu治疗晚期食管癌的疗效对比
引用本文:史晓宇,韩宇,周建华,王丽杰,白玉贤.奈达铂联合5-Fu与顺铂联合5-Fu治疗晚期食管癌的疗效对比[J].肿瘤防治研究,2008,35(5):358-360.
作者姓名:史晓宇  韩宇  周建华  王丽杰  白玉贤
作者单位:哈尔滨医科大学附属肿瘤医院内二科;
摘    要:目的对比观察奈达铂(nedaplatin,NDP)联合氟尿嘧啶(5-Fu)和顺铂(cisplatin,CDDP)联合5-Fu治疗晚期食管癌的近期疗效。方法采集61例病例,NDP+5-Fu组(NF组)30例,CDDP+5-Fu组(DF组)31例,NF组采用NDP80~100mg/m2,静脉滴注,d1,亚叶酸钙200mg/m2,静脉滴注,d1、2,5-Fu400mg/m2,静脉推注,然后5-Fu600mg/m2持续静脉滴注约22h,d1、2;DF组采用CDDP30mg/m2,静脉滴注,d1~3,其他药物的用法同NF组。结果NF组和DF组的有效率分别为53.33%和35.48%,无显著差异(P>0.05);NF组消化道不良反应小,肝肾毒性轻微。结论NDP治疗晚期食管癌近期疗效不低于CDDP,副作用易于耐受,因此特别适合老年人采用,对CDDP治疗失败或不能耐受CDDP不良反应的病例仍有一定疗效。

关 键 词:奈达铂  顺铂  晚期食管癌  
文章编号:1000-8578(2008)05-0358-03
收稿时间:2007-5-18
修稿时间:2007年5月18日

Effect Contrasting of Nedaplatin plus 5-Fu and Cisplatin plus 5-Fu in Treatment with Advanced Esophageal Carcinoma
SHI Xiao-yu,HAN Yu,ZHOU Jian-hua,WANG Li-Jie,BAI Yu-xian.Effect Contrasting of Nedaplatin plus 5-Fu and Cisplatin plus 5-Fu in Treatment with Advanced Esophageal Carcinoma[J].Cancer Research on Prevention and Treatment,2008,35(5):358-360.
Authors:SHI Xiao-yu  HAN Yu  ZHOU Jian-hua  WANG Li-Jie  BAI Yu-xian
Institution:The Second Department of Internal Medicine; Affiliated Tumor Hospital of Harbin Medcine University; Harbin 150040; China;
Abstract:Objective  To observe the efficacy in the near future of nedaplatin (NDP) and cisplatin (CDDP) for the patient s with advanced esophageal carcinoma. Methods  Collect 61cases ,30 cases in NDP t reat2 ment group (NF group) ,31 cases in CDDP t reatment group (DF group) ,NF group use NDP 80~100 mg/ m2 ,int ravenous drip ,d1 ,calcium leucovorin 200 mg/ m2 ,int ravenous drip ,d1 ,2 ,then int ravenous bolus of 52Fu 400 mg/ m2 followed by 22 hour infusion of 52Fu 600 mg/ m2 using an ambulatory pump ,d1 ,2 ;DF group use CDDP 30mg/ m2 ,int ravenous drip ,d1~3 ,the usage of other drugs are the same as DF group. Results  The RR of NF group is 53. 33 % ,the RR of DF group is 35. 48 % ,the difference was not statisti2 cally significant ( P > 0. 05) . There is a lower digestive reaction and lower toxicity of liver and kidney in NF group. Conclusion  The efficacy in the near future of NF group is higher than DF group and NF group is easier tolerant to the side effect ,so it is fit to the olds especially and do has efficacy to the pa2 tient s failure or cannot tolerate to CDDP.
Keywords:Nedaplatin  Cisplatin  Advanced esophageal carcinoma
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号